Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
ORGO on Nasdaq
Shares outstanding
126,404,443
Price per share
$4.21
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
56,941,492
Total reported value
$294,780,848
% of total 13F portfolios
0%
Share change
+627,838
Value change
+$3,372,228
Number of holders
98
Price from insider filings
$4.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ades Alan A. 18% -1.1% $66,289,913 22,319,836 0% Alan A. Ades 24 Jun 2025
NUSSDORF GLENN H 9.7% $51,688,923 12,248,560 Glenn H. Nussdorf 14 May 2025
Soleus Capital Master Fund, L.P. 7.9% -20% $42,040,854 -$10,520,474 9,985,951 -20% Soleus Capital Master Fund, L.P. 31 Dec 2025
First Light Asset Management, LLC 6.6% $35,730,437 8,309,404 Mathew P. Arens 30 Jun 2025

As of 31 Dec 2025, 98 institutional investors reported holding 56,941,492 shares of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO). This represents 45% of the company’s total 126,404,443 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 9.2% 11,638,836 -1.3% 0% $60,289,171
Soleus Capital Management, L.P. 7.9% 9,985,951 -18% 2.2% $51,727,226
Assenagon Asset Management S.A. 4.4% 5,535,334 +14% 0.04% $28,673,030
VANGUARD GROUP INC 3.9% 4,958,876 -1.5% 0% $25,686,978
BlackRock, Inc. 3.8% 4,761,094 +3.8% 0% $24,662,466
DEUTSCHE BANK AG\ 2.6% 3,297,631 +0.4% 0.01% $17,081,729
DIMENSIONAL FUND ADVISORS LP 2.2% 2,730,980 -6.1% 0% $14,146,476
GEODE CAPITAL MANAGEMENT, LLC 1.4% 1,786,978 +3.6% 0% $9,258,857
STATE STREET CORP 1.2% 1,519,272 -0.11% 0% $7,869,829
ACADIAN ASSET MANAGEMENT LLC 1.2% 1,460,359 -17% 0.01% $7,561,000
NORGES BANK 0.87% 1,097,600 0% $5,685,568
JANE STREET GROUP, LLC 0.7% 881,687 +904% 0.01% $4,567,139
RENAISSANCE TECHNOLOGIES LLC 0.65% 818,700 -0.34% 0.01% $4,240,866
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.56% 706,699 -18% 0% $3,660,701
SG Americas Securities, LLC 0.45% 565,501 +199% 0% $2,929,000
GOLDMAN SACHS GROUP INC 0.33% 418,244 +82% 0% $2,166,504
Wealth Dimensions Group, Ltd. 0.32% 407,965 0% 0.42% $2,113,259
WELLS FARGO & COMPANY/MN 0.28% 353,365 +742% 0% $1,830,431
SEGALL BRYANT & HAMILL, LLC 0.25% 319,322 +0.19% 0.02% $1,654,088
HighMark Wealth Management LLC 0.24% 303,029 +3.4% 0.64% $1,569,691
Bank of New York Mellon Corp 0.24% 302,624 -19% 0% $1,567,592
HRT FINANCIAL LP 0.22% 274,814 0% $1,423,000
Nuveen, LLC 0.22% 273,975 +73% 0% $1,419,190
Hennion & Walsh Asset Management, Inc. 0.16% 208,341 +31% 0.04% $1,079,206
GSA CAPITAL PARTNERS LLP 0.15% 191,465 0.09% $992,000

Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 56,941,492 $294,780,848 +$3,372,228 $5.18 98
2025 Q3 68,429,157 $288,726,812 -$3,866,945 $4.22 120
2025 Q2 69,383,599 $253,970,094 +$15,169,482 $3.66 113
2025 Q1 64,527,988 $278,764,897 +$10,290,470 $4.32 135
2024 Q4 62,559,435 $200,195,689 -$4,632,565 $3.20 119
2024 Q3 63,992,032 $183,024,939 +$3,073,151 $2.86 111
2024 Q2 62,887,604 $176,087,539 +$15,313,422 $2.80 114
2024 Q1 57,059,906 $162,044,497 -$4,218,961 $2.84 123
2023 Q4 58,271,447 $238,328,151 +$24,483,565 $4.09 107
2023 Q3 52,567,125 $167,155,866 +$2,434,079 $3.18 103
2023 Q2 51,683,797 $171,584,944 -$2,458,393 $3.32 111
2023 Q1 53,442,433 $113,798,804 -$5,356,219 $2.13 130
2022 Q4 56,005,330 $150,650,419 +$1,931,028 $2.69 146
2022 Q3 55,031,412 $178,300,322 -$19,442,671 $3.24 144
2022 Q2 58,051,832 $283,327,408 -$3,172,672 $4.88 140
2022 Q1 57,887,989 $440,942,195 +$10,319,977 $7.62 147
2021 Q4 55,836,563 $515,731,659 -$2,571,363 $9.24 151
2021 Q3 53,370,851 $762,477,663 +$42,467,188 $14.24 141
2021 Q2 49,939,204 $830,012,497 +$410,032,084 $16.62 140
2021 Q1 24,855,592 $453,129,001 +$68,036,540 $18.22 99
2020 Q4 21,338,757 $160,687,218 +$122,816,812 $7.53 65
2020 Q3 4,977,699 $19,103,728 +$2,285,403 $3.84 47
2020 Q2 4,380,098 $16,755,945 +$2,234,312 $3.84 47
2020 Q1 3,847,640 $12,393,195 -$1,227,774 $3.23 50
2019 Q4 4,058,177 $19,521,798 +$10,098,739 $4.81 53
2019 Q3 1,894,140 $12,445,423 +$1,959,070 $6.57 37
2019 Q2 1,463,592 $11,124,205 +$4,972,528 $7.60 27
2019 Q1 812,507 $6,092,000 +$6,092,000 $7.50 16
2018 Q4 $10.15 0